News / Health

    Malaria Vaccine Offers Hope

    This undated photo supplied by WGBH/Nova shows a mosquito at work.
    This undated photo supplied by WGBH/Nova shows a mosquito at work.

    Related Articles

    Study: Pregnant Women Not Gaining Access to Malaria Prevention

    Malaria infections, primarily in sub-Saharan Africa, responsible for deaths of some 200,000 newborns and 10,000 new mothers each year

    Audio Warmer Temps Trigger More Disease

    Scientists say climate change creating favorable environment for germs, pests
    VOA News
    An experimental malaria vaccine appears to offer protection against infection in healthy adults, according to U.S. researchers. The researchers also say early results indicate the vaccine is safe and “generated an immune response” in the group of volunteers tested.

    The vaccine, known as PfSPZ, is composed of live but weakened sporozoites of the species Plasmodium falciparum, the most deadly of the malaria-causing parasites.

    Malaria is transmitted to humans by the bite of an infected mosquito. After the bite occurs, infectious malaria parasites in the immature, sporozoite stage of their life cycle, first travel to the liver, where they multiply, and then spread through the bloodstream.

    “In this trial, we showed in principle that sporozoites can be developed into a malaria vaccine that confers high levels of protection and is made using the good manufacturing practices that are required for vaccine licensure,” said Dr. Robert A. Seder, chief of the Cellular Immunology Section of the NIAID Vaccine Research Center and principal investigator of the trial.

    One potential drawback to the vaccine is that it appeared most effective when administered intravenously because lower doses given under the skin did not yield similar results.

    “Despite this challenge, these trial results are a promising first step in generating high-level protection against malaria, and they allow for future studies to optimize the dose, schedule and delivery route of the candidate vaccine,” said Seder.

    Fifty-seven adults between 18 and 45 years old took part in Phase One of the trial. Forty received the vaccine and 17 did not. Some of those who received the vaccine were given increasing doses. After seven days of monitoring, “no severe adverse effects associated with the vaccine occurred, and no malaria infections related to vaccination were observed.”

    Furthermore, those who received the most vaccine generated more antibodies against malaria, researchers said.

    Three weeks after the last dosage, participants -- both those who received the vaccine and the control group -- were exposed to bites from five mosquitoes carrying the P. falciparum strain from which the PfSPZ Vaccine was derived.

    The researchers found that the higher dosages of PfSPZ Vaccine were associated with protection against malaria infection. Only three of the 15 participants who received higher doses of the vaccine became infected, compared to 16 of 17 participants in the lower dose group who became infected. Among the 12 participants who received no vaccine, 11 participants became infected, researchers said.

    Researchers say they plan several follow-up studies to test dosage schedules and whether larger doses delivered under the skin can offer the same immune response.

    “The global burden of malaria is extraordinary and unacceptable,” said Dr. Anthony Fauci, the NIAID director. “Scientists and health care providers have made significant gains in characterizing, treating and preventing malaria; however, a vaccine has remained an elusive goal. We are encouraged by this important step forward.”

    The vaccine was developed by scientists at Sanaria Inc. The clinical evaluation was conducted by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and their collaborators at the Walter Reed Army Institute of Research and the Naval Medical Research Center.

    The results of the study were published in the August 8 issue of Science.

    You May Like

    Chechen Suspected in Istanbul Attack, but Questions Remain

    Turkish sources say North Caucasus militants involved in bombing at Ataturk airport, but name of at least one alleged attacker raises doubts

    With Johnson Out, Can a New ‘Margaret Thatcher’ Save Britain?

    Contest to replace David Cameron as Britain’s prime minister started in earnest Thursday with top candidates outlining strategy to deal with Brexit fallout

    US Finds Progress Slow Against Human Trafficking in Africa

    Africa continues to be a major source and destination for human trafficking of all kinds -- from forced labor to sexual slavery, says State Department report

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: Toogee from: South Lake Tahoe
    August 11, 2013 9:31 PM
    This pic shown is that of an Aedes aegypti, which vectors a few nasty pathogens like dengue fever, chikungunya and yellow fever, but isn't a primary vector of malaria, is it?

    by: kooni from: missipi
    August 11, 2013 6:50 PM
    they weren't actually bitten by the mosquito you idiot, there blood was tested with the malaria to see if the white cells respond to it.

    by: Cranksy from: USA
    August 09, 2013 1:31 PM
    "Three weeks after the last dosage, participants -- both those who received the vaccine and the control group -- were exposed to bites from five mosquitoes carrying the P. falciparum strain from which the PfSPZ Vaccine was derived." I read the linked material that stated "[t]his controlled human malaria infection procedure — a standard process in malaria vaccine trials...." Isn't this type of exposure considered unethical? Volunteers or not these people didn't simply remain or return to the places where they live their lives to be naturally exposed to P. falciparum "the most deadly form of the malaria-causing parasites."

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Clinton Leads Trump, But Many Voters Don't Like Eitheri
    X
    Jim Malone
    June 29, 2016 6:16 PM
    In the U.S. presidential race, most recent polls show Democrat Hillary Clinton with a steady lead over Republican Donald Trump as both presumptive party nominees prepare for their party conventions next month. Trump’s disapproval ratings have risen in some recent surveys, but Clinton also suffers from high negative ratings, suggesting both candidates have a lot of work to do to improve their images before the November election. VOA National correspondent Jim Malone has more from Washington.
    Video

    Video Clinton Leads Trump, But Many Voters Don't Like Either

    In the U.S. presidential race, most recent polls show Democrat Hillary Clinton with a steady lead over Republican Donald Trump as both presumptive party nominees prepare for their party conventions next month. Trump’s disapproval ratings have risen in some recent surveys, but Clinton also suffers from high negative ratings, suggesting both candidates have a lot of work to do to improve their images before the November election. VOA National correspondent Jim Malone has more from Washington.
    Video

    Video Slow Rebuilding Amid Boko Haram Destruction in Nigeria’s Northeast

    Military operations have chased Boko Haram out of towns and cities in Nigeria’s northeast since early last year. But it is only recently that people have begun returning to their homes in Adamawa state, near the border with Cameroon, to try to rebuild their lives. For VOA, Chris Stein traveled to the area and has this report.
    Video

    Video New US Ambassador to Somalia Faces Heavy Challenges

    The new U.S. envoy to Somalia, who was sworn into office Monday, will be the first American ambassador to that nation in 25 years. He will take up his post as Somalia faces a number of crucial issues, including insecurity, an upcoming election, and the potential closure of the Dadaab refugee camp in Kenya. VOA’s Jill Craig asked Somalis living in Kenya’s capital city Nairobi how they feel about the U.S. finally installing a new ambassador.
    Video

    Video At National Zoo, Captivating Animal Sculptures Illustrate Tragedy of Ocean Pollution

    The National Zoo in Washington, D.C., is home to about 1,800 animals, representing 300 species. But throughout the summer, visitors can also see other kinds of creatures there. They are larger-than-life animal sculptures that speak volumes about a global issue — the massive plastic pollution in our oceans. VOA's June Soh takes us to the zoo's special exhibit, called Washed Ashore: Art to Save the Sea.
    Video

    Video Baghdad Bikers Defy War with a Roar

    Baghdad is a city of contradictions. War is a constant. Explosions and kidnappings are part of daily life. But the Iraqi capital remains a thriving city, even if a little beat up. VOA's Sharon Behn reports on how some in Baghdad are defying the stereotype of a nation at war by pursuing a lifestyle known for its iconic symbols of rebellion: motorbikes, leather jackets and roaring engines.
    Video

    Video Melting Pot of Immigrants Working to Restore US Capitol Dome

    The American Iron Works company is one of the firms working to renovate the iconic U.S. Capitol Dome. The company employs immigrants of many different cultural and national backgrounds. VOA’s Arman Tarjimanyan has more.
    Video

    Video Testing Bamboo as Building Material

    For thousands of years various species of bamboo - one of the world's most versatile plants - have been used for diverse purposes ranging from food and medicine to textiles and construction. But its use on a large scale is hampered because it's not manufactured to specific standards but grown in the ground. A University of Pittsburgh professor is on track to changing that. VOA’s George Putic reports.
    Video

    Video Orphanage in Iraqi City Houses Kids Who Lost their Parents to Attacks by IS

    An orphanage in Iraqi Kurdistan has become home to scores of Yazidi children who lost their parents after Islamic State militants took over Sinjar in Iraq’s Nineveh Province in 2014. Iraqi Kurdish forces backed by the U.S. airstrikes have since recaptured Sinjar but the need for the care provided by the orphanage continues. VOA’s Kawa Omar filed this report narrated by Rob Raffaele.
    Video

    Video Re-Opening Old Wounds in a Bullet-Riddled Cultural Landmark

    A cultural landmark before Lebanon’s civil war transformed it into a nest of snipers, Beirut’s ‘Yellow House’ is once again set to play a crucial role in the city.  Built in a neo-Ottoman style in the 1920s, in September it is set to be re-opened as a ‘memory museum’ - its bullet-riddled walls and bunkered positions overlooking the city’s notorious ‘Green Line’ maintained for posterity. John Owens reports from Beirut.
    Video

    Video Brexit Resounds in US Presidential Contest

    Britain’s decision to leave the European Union is resounding in America’s presidential race. As VOA’s Michael Bowman reports, Republican presumptive nominee Donald Trump sees Britain’s move as an affirmation of his campaign’s core messages, while Democrat Hillary Clinton sees the episode as further evidence that Trump is unfit to be president.
    Video

    Video NASA Juno Spacecraft, Nearing Jupiter, to Shed Light on Gas Giant

    After a five-year journey, the spacecraft Juno is nearing its destination, the giant planet Jupiter, where it will enter orbit and start sending data back July 4th. As Mike O'Sullivan reports from Pasadena, California, the craft will pierce the veil of Jupiter's dense cloud cover to reveal its mysteries.
    Video

    Video Orlando Shooting Changes Debate on Gun Control

    It’s been nearly two weeks since the largest mass shooting ever in the United States. Despite public calls for tighter gun control laws, Congress is at an impasse. Democratic lawmakers resorted to a 1960s civil rights tactic to portray their frustration. VOA’s Carolyn Presutti explains how the Orlando, Florida shooting is changing the debate.

    Special Report

    Adrift The Invisible African Diaspora